Terms: = Pancreatic cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Diagnosis
16 results:
1. Coagulation parameters for the differential diagnosis of pancreatic cancer in the early stage: a retrospective study.
Jiaao L; Wanli G; Kai Z; Feng G; Yunpeng P
Eur J Med Res; 2023 Oct; 28(1):436. PubMed ID: 37848965
[TBL] [Abstract] [Full Text] [Related]
2. Germline Genetic Testing After cancer diagnosis.
Kurian AW; Abrahamse P; Furgal A; Ward KC; Hamilton AS; Hodan R; Tocco R; Liu L; Berek JS; Hoang L; Yussuf A; Susswein L; Esplin ED; Slavin TP; Gomez SL; Hofer TP; Katz SJ
JAMA; 2023 Jul; 330(1):43-51. PubMed ID: 37276540
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy.
Park H; Bang JH; Nam AR; Park JE; Jin MH; Bang YJ; Oh DY
Cancer Med; 2020 Jan; 9(1):43-51. PubMed ID: 31701645
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract] [Full Text] [Related]
5. Significance and prognostic value of increased serum direct bilirubin level for lymph node metastasis in Chinese rectal cancer patients.
Gao C; Fang L; Li JT; Zhao HC
World J Gastroenterol; 2016 Feb; 22(8):2576-84. PubMed ID: 26937145
[TBL] [Abstract] [Full Text] [Related]
6. Plasma miRNAs Effectively Distinguish Patients With pancreatic cancer From Controls: A Multicenter Study.
Xu J; Cao Z; Liu W; You L; Zhou L; Wang C; Lou W; Sun B; Miao Y; Liu X; Zhang T; Zhao Y
Ann Surg; 2016 Jun; 263(6):1173-9. PubMed ID: 26114496
[TBL] [Abstract] [Full Text] [Related]
7. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
[TBL] [Abstract] [Full Text] [Related]
8. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
[TBL] [Abstract] [Full Text] [Related]
9. pancreaticobiliary maljunction is associated with common bile duct carcinoma: a meta-analysis.
Li Y; Wei J; Zhao Z; You T; Zhong M
ScientificWorldJournal; 2013; 2013():618670. PubMed ID: 24489507
[TBL] [Abstract] [Full Text] [Related]
10. Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer.
Sandrasegaran K; Nutakki K; Tahir B; Dhanabal A; Tann M; Cote GA
AJR Am J Roentgenol; 2013 Nov; 201(5):1002-8. PubMed ID: 24147470
[TBL] [Abstract] [Full Text] [Related]
11. Uptake and patterns of use of gemcitabine for metastatic pancreatic cancer: a population-based study.
Oberstein PE; Hershman DL; Khanna LG; Chabot JA; Insel BJ; Neugut AI
Cancer Invest; 2013 Jun; 31(5):316-22. PubMed ID: 23614655
[TBL] [Abstract] [Full Text] [Related]
12. Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. PANKRAS II Study Group.
Porta M; Costafreda S; Malats N; Guarner L; Soler M; Gubern JM; García-Olivares E; Andreu M; Salas A; Corominas JM; Alguacil J; Carrato A; Rifà J; Real FX
Eur J Epidemiol; 2000 Jun; 16(6):533-41. PubMed ID: 11049097
[TBL] [Abstract] [Full Text] [Related]
13. Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. PANKRAS II Study Group.
Soler M; Malats N; Porta M; Fernandez E; Guarner L; Maguire A; Pinõl JL; Rifà J; Carrato A
Dig Dis Sci; 1999 Dec; 44(12):2469-77. PubMed ID: 10630499
[TBL] [Abstract] [Full Text] [Related]
14. Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer.
Soler M; Porta M; Malats N; Guarner L; Costafreda S; Gubern JM; García-Olivares E; Andreu M; Real FX
J Clin Epidemiol; 1998 Dec; 51(12):1215-21. PubMed ID: 10086813
[TBL] [Abstract] [Full Text] [Related]
15. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
[TBL] [Abstract] [Full Text] [Related]
16. [Differential diagnosis of tumors of the duodenal bulb by endoscopy and biopsy (author's transl)].
Wolfert W; Probst M; Schachenmayr W; Goebell H
Leber Magen Darm; 1977 Feb; 7(1):46-53. PubMed ID: 839953
[TBL] [Abstract] [Full Text] [Related]
